Annual Information Update

RNS Number : 9750J

AstraZeneca PLC

09 April 2010

 



 

ASTRAZENECA PLC

ANNUAL INFORMATION UPDATE

As required under the Prospectus (Directive 2003/71/EC) Regulations 2005 and paragraph 5.2 of the Prospectus Rules, and following publication of the Annual Report and Form 20-F Information on 15 March 2010, AstraZeneca PLC is presenting its Annual Information Update in relation to information that has been published or made available to the public between 20 March 2009 and 8 April 2010.

This Annual Information Update is also being made available on the Investors section of our website, www.astrazeneca.com.

The information referred to in this Annual Information Update was correct at the time it was published but may now be out of date.

1. Announcements made via a RIS

The documents listed below were published via a Regulatory Information Service on or around the dates indicated.

Date	Description of Contents of Announcement
20/03/09	Annual Information Update
25/03/09	Director/PDMR Shareholding
25/03/09	Director/PDMR Shareholding
30/03/09	Director/PDMR Shareholding
30/03/09	Director/PDMR Shareholding
30/03/09	Director/PDMR Shareholding
30/03/09	Director/PDMR Shareholding
31/03/09	Total Voting Rights
01/04/09	Director/PDMR Shareholding
02/04/09	Onglyza
02/04/09	Director/PDMR Shareholding
03/04/09	Seroquel PDAC
06/04/09	Symbicort CRL
06/04/09	OTC Portfolio Divestment
07/04/09	Apotex re Pulmicort
09/04/09	Seroquel XR PDAC
17/04/09	Pulmicort TRO - Apotex
23/04/09	Onglyza PDUFA
23/04/09	Iressa CHMP
29/04/09	Notice of Results
30/04/09	AGM Poll Results
30/04/09	Total Voting Rights
07/05/09	AGM Resolutions filed with UKLA
11/05/09	Brilinta PLATO
20/05/09	PDMR PSP Interests [DRB]
21/05/09	Pulmicort : Injunction against Apotex
27/05/09	Director/PDMR Shareholding
29/05/09	Seroquel XR
29/05/09	Total Voting Rights
04/06/09	AstraZeneca+Abbott re Certriad
11/06/09	Seroquel Paediatric SNDA
26/06/09	Onglyza CHMP
30/06/09	Total Voting Rights
01/07/09	Iressa : Europe
01/07/09	Director/PDMR Shareholding
09/07/09	MAP Pharmaceuticals
29/07/09	Notice of Results
21/07/09	Director/PDMR Shareholding
31/07/09	Total Voting Rights
03/08/09	Onglyza
26/08/09	Director/PDMR Shareholding
01/09/09	Brilinta
01/09 09	Total Voting Rights
01/09/09	Director/PDMR Shareholding
04/09/09	Euro Medium Term Note Programme
08/09/09	Director/PDMR Shareholding
21/09/09	NKTR-118
28/09/09	Seroquel
01/10/09	Total Voting Rights
05/10/09	Onglyza
06/10/09	Holding(s) in Company
28/10/09	Notice of Results : Q3
28/10/09	Zactima
30/10/09	Director/PDMR Shareholding
02/11/09	Total Voting Rights
19/11/09	Brilinta NDA
01/12/09	Total Voting Rights
03/12/09	Targacept Collaboration
04/12/09	Seroquel XR
08/12/09	TR1 - BlackRock, Inc
11/12/09	Crestor : Briefing Materials
16/12/09	Crestor : FDA Vote Result
23/12/09	Novexel + Forest
24/12/09	Motavizumab CRL Response
04/01/10	Total Voting Rights
07/01/10	Teva : Nexium/Prilosec Settlement
27/01/10	Notice of Results
27/01/10	Director/PDMR Shareholding
01/02/10	Director/PDMR Shareholding
01/02/10	Total Voting Rights
09/02/10	Crestor JUPITER Approval
16/02/10	Rigel Pharma
23/02/10	Transaction in Own Shares
23/02/10	UK Tax Settlement
24/02/10	Director/PDMR Shareholding
24/02/10	Director/PDMR Shareholding
26/02/10	Director/PDMR Shareholding
26/02/10	Director/PDMR Shareholding
01/03/10	Merck Agreement UpDate
01/03/10	Total Voting Rights
03/03/10	Director/PDMR Shareholding
05/03/10	Director/PDMR Shareholding
08/03/10	Recentin HORIZON III
09/03/10	Transaction in Own Shares
11/03/10	Torrent  Pharmaceuticals
11/03/10	Director/PDMR Shareholding
15/03 10	Notice of Emerging Markets Event
15/03/10	Publication of Annual Report for 2009
15/03/10	Board Changes
18/03/10	Transaction in Own Shares
18/03/10	Seroquel : Product Liability Trial Update
25/03/10	Transaction in Own Shares
26/03/10	Transaction in Own Shares
29/03/10	Transaction in Own Shares
29/03/10	Director/PDMR Shareholding
30/03/10	Transaction in Own Shares
30/03/10	Certriad CRL
30/03/10	Share RePurchase Programme
31/03/10	Director/PDMR Shareholding
31/03/10	Director/PDMR Shareholding
01/04/10	Transaction in Own Shares
01/04/10	Director/PDMR Shareholding
01/04/10	Total Voting Rights
06/04/10	Transaction in Own Shares
07/04/10	Transaction in Own Shares
08/04/10	Transaction in Own Shares
08/04/10	Filing of Annual Report on SEC Form 20F

All of the above documents are available for download on the Prices and News section of the London Stock Exchange website, www.londonstockexchange.com.

2. Documents filed at Companies House

All of the documents below were filed with the Registrar of Companies in England and Wales on or around the dates indicated.

Date	Document type
01/04/09	Form 288b - Director Resigned
01/05/09	Form 288b - Director Resigned
12/05/09	Resolutions after AGM 2009
03/06/09	Group of Companies' Accounts made up to 31/12/08
16/06/09	Form 288c - Director's change of particulars
08/07/09	Form 363 - Return made up to 15/05/09
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
08/07/09	Form 169 - Return by a Company Purchasing its Own Shares
06/10/09	Form AD02 - SAIL address created
06/10/09	Form AD03 - Register(s) moved to SAIL address

All of the documents above are available for download from the Companies House website at www.companieshouse.gov.uk, or can be obtained from Companies House, Crown Way, Maindy, Cardiff, CF14 3UZ.

3. Documents submitted to the FSA

All the documents below were submitted to the FSA on or around the dates indicated.

Date	Document
07/05/09	AGM Resolutions
04/09/09	Euro Medium Term Note Prospectus
15/03/10	Annual Report and Form 20-F Information 2009
15/03/10	Notice of AGM 2010 and Shareholders' Circular
15/03/10	Shareholder Letter 2009

Documents submitted to the FSA can be viewed at the Document Viewing Facility situated at The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London, E14 5HS.

The Notice of AGM, Annual Report and Form 20-F Information and Shareholder Letter are also available via the Investors section of our website, www.astrazeneca.com.

4. Documents lodged with the Securities and Exchange Commission

The documents listed below were filed with the SEC on or around the dates indicated.

Date	Document
06/04/09	Form 6-K Quarterly Reports
07/05/09	Form 6-K Quarterly Reports
08/06/09	Form 6-K Quarterly Reports
25/06/09	Form 11-K
10/07/09	Form 6-K Quarterly Reports
12/08/09	Form 6-K Quarterly Reports
16/09/09	Form 6-K Quarterly Reports
17/09/09	Form 25-NSE
07/10/09	Form 6-K Quarterly Reports
12/11/09	Form 6-K Quarterly Reports
07/12/09	Form 6-K Quarterly Reports
09/12/09	Form F-6EF
07/01/10	Form 6-K Quarterly Reports
29/01/10	Form SC 13G
05/02/10	Form 6-K Quarterly Reports
04/03/10	Form 6-K Quarterly Reports
25/03/10	Form 6-K Quarterly Reports
25/03/10	Form 20-F Annual Report 2009

All of the documents above are available for viewing on the Investor section of our website, www.astrazeneca.com.

5.  Further Information

Further information about AstraZeneca PLC can be found at our website, www.astrazeneca.com.

 

END

 

 

AIUILMTTMBJMBAM